Graf Acquisition Corp. IV (GFOR) Adds $10M in Note Funding to NKGen Biotech Deal
by Nicholas Alan Clayton on 2023-09-18 at 10:15am

Graf Acquisition Corp. IV (NYSE:GFOR) announced in an 8-K this morning that it has added $10 million in convertible note funding to its combination with NKGen Biotech.

NKGen’s majority shareholder NKMax (KOSDAQ:182400) has put up the cash for the move and in exchange the notes are to bear interest payable at either a 5% rate in cash or 8% in stock. They will mature in 2027 on the agreement’s fourth anniversary and can be exercised for 1,000,000 shares at $11.50 per share.

This new funding comes as Graf IV has postponed its completion vote with NKGen three times as it engages with shareholders and tries to hit its $50 million minimum cash condition.

Its shareholders are currently set to reconvene at 10 am ET, September 20 and it has until September 25 to complete a deal.

Graf IV went into this string of meetings with about $62.2 million in trust and NKMax had already committed to a backstop of up to $25 million. According to the filing, the SPAC plans to continue to seek out additional funds to bring the deal to a close.

The $160 million combination was initially announced in April of this year. Santa Ana, California-based NKGen has five pharmaceutical formulas that have each reached some stage of Phase I and Phase II clinical trials seeking potential therapies for cancer and neurodegenerative conditions like Parkinson’s and Alzheimer’s.

Recent Posts
by Nicholas Alan Clayton on 2024-05-23 at 7:54am

At the SPAC of Dawn When British regulators adopted new SPAC rules in 2021, it was in part to try and lure more business back to UK exchanges while the SPAC boom was ongoing in the US. Instead, UK-based SPAC volume has remained low and the country’s latest SPAC deal will actually take its target...

by Nicholas Alan Clayton on 2024-05-22 at 1:59pm

Perceptive Capital Solutions (NASDAQ:PCSC) has filed for a $75 million IPO with an experienced team able to drive ambitious terms. It becomes just the second SPAC in six months to file for a vehicle without either warrants or rights and it would become one of a select few teams that have gotten such a vehicle...

by Nicholas Alan Clayton on 2024-05-22 at 7:42am

At the SPAC of Dawn Autonomous driving de-SPACs gained a new playground this week as the UK has passed expansive new legislation allowing for autonomous vehicle testing and use on British roads. The new law will clarify liability issues around collisions and beef up its regulatory arm that considers new vehicles to be approved for...

by Kristi Marvin on 2024-05-22 at 7:35am

Providing dedicated power to industrial facilities is a task that has drawn in a variety of different energy technologies and, increasingly, a variety of SPAC transactions. This week, we speak with Jereme Kent, founder and CEO of One Energy. One Energy provides dedicated clean power generation to industrial clients allowing them to lock in cheaper energy,...

by Nicholas Alan Clayton on 2024-05-21 at 7:49am

At the SPAC of Dawn Yesterday’s trading provided a jumpy session for some of the highest profile recent de-SPACs with crypto marketplace Bakkt (NYSE:BKKT) leaping +45% to $16.65, although this price would be $0.67 adjusted for stock splits. DTC health firm Hims (NYSE:HIMS) and EV maker VinFast (NASDAQ:VFS) each gained more than +25% on the...

logo

Copyright © 2023 SPACInsider, Inc. All Rights Reserved